STOCK TITAN

iRhythm (IRTC) chief medical officer sells 1,423 shares for RSU tax withholding

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

iRhythm Holdings, Inc. executive reports share sale tied to tax obligations. Chief Medical and Scientific Officer Minang Turakhia reported the sale of 1,423 shares of common stock on July 2, 2026 at an average price of $124.71 per share. A footnote explains these shares were sold to cover tax withholding and remittance obligations related to the vesting of Restricted Stock Units. After this transaction, Turakhia directly holds 53,620 shares of iRhythm common stock.

Positive

  • None.

Negative

  • None.
Insider Turakhia Minang
Role CHIEF MED/SCI OFCR EVP ADVTECH
Sold 1,423 shs ($177K)
Type Security Shares Price Value
Sale Common Stock 1,423 $124.71 $177K
Holdings After Transaction: Common Stock — 53,620 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 1,423 shares Common Stock sold on July 2, 2026
Sale price $124.71 per share Average price for the 1,423 shares sold
Shares held after transaction 53,620 shares Direct ownership after July 2, 2026 sale
Transaction type Open-market sale, tax-related Sale to cover tax withholding on RSU vesting
Restricted Stock Units (RSUs) financial
"in connection with the vesting of Restricted Stock Units (RSUs)"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
tax withholding financial
"sold to cover tax withholding and remittance obligations"
Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Turakhia Minang

(Last)(First)(Middle)
C/O IRHYTHM HOLDINGS, INC.
699 8TH ST #600

(Street)
SAN FRANCISCO CALIFORNIA 94103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF MED/SCI OFCR EVP ADVTECH
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/202607/02/2026S1,423(1)D$124.7153,620D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).
Remarks:
/s/ Marc Rosenbaum, attorney-in-fact07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did iRhythm Holdings (IRTC) report for Minang Turakhia?

iRhythm reported that executive Minang Turakhia sold 1,423 shares of common stock. The transaction occurred on July 2, 2026 at an average price of $124.71 per share and was linked to tax obligations on vesting RSUs.

Why did Minang Turakhia sell iRhythm (IRTC) shares in this Form 4 filing?

The shares were sold to cover tax withholding and remittance obligations arising from the vesting of Restricted Stock Units. This indicates the sale was driven by tax requirements associated with equity compensation, rather than a standalone open-market portfolio decision.

How many iRhythm (IRTC) shares does Minang Turakhia hold after the reported transaction?

Following the reported transaction, Minang Turakhia directly holds 53,620 shares of iRhythm common stock. This post-transaction holding shows that the tax-related sale was small relative to the remaining equity position disclosed in the filing.

What was the price of the iRhythm (IRTC) shares sold by Minang Turakhia?

The 1,423 iRhythm common shares were sold at an average price of $124.71 per share. This price is based on the transaction details disclosed in the Form 4 and reflects the sale used to satisfy tax withholding obligations.

Does the Form 4 indicate any derivative or option exercises for iRhythm (IRTC)?

The filing does not show any derivative transactions or option exercises. It reports only one non-derivative transaction involving common stock, connected to tax withholding on vested Restricted Stock Units, with no remaining derivative positions listed in the derivative summary.